YAKUKENSHA CO.,LTD.

YAKUKENSHA CO.,LTD. provides a broad portfolio of testing services, including blood and urine testing, toxicity studies, and safety pharmacology studies. This section introduces the characteristics of YAKUKENSHA’s nonclinical studies, presents an example disease model, and outlines case studies. This information is provided as a reference when selecting a vendor/CRO for nonclinical studies.

Nonclinical Studies Undertaken by YAKUKENSHA CO.,LTD.

YAKUKENSHA CO.,LTD. provides contract nonclinical study services with a particular emphasis on drug discovery support and safety studies. Specifically, the company conducts toxicity studies, safety pharmacology studies, and pharmacodynamic/efficacy studies using genetically engineered animals. These studies are primarily used during the drug development stage, and YAKUKENSHA also supports evaluations of medical devices and biopharmaceuticals.

YAKUKENSHA CO.,LTD. also employs CRISPR/Cas9 technology to generate genetically engineered mice and perform phenotypic analysis, supporting research in psychiatric and neurologic disorders and allergic diseases. These services contribute to studies using models of Alzheimer’s disease and atopic dermatitis, among others.

Contract Research Partners Offered Through YAKUKENSHA CO.,LTD.

SetsuroTech Inc.

Provides phenotypic analysis services for generated mice on a contract basis. Capabilities include assays for oxidative stress markers in blood, cytokine detection, and pharmacology/efficacy studies. The company also supports breeding, husbandry, and colony expansion for mouse production.

TRANS GENIC INC.

Provides nonclinical testing services utilizing advanced genetically engineered mice. Disease-model lines established and characterized at universities and research institutes are available under license. Disease-specific models include APPosk-Tg mice for Alzheimer’s disease research, ProBDNF KI mice for psychiatric and neurologic disorders, SJLB mice for dementia research, and IL33 Tg mice for atopic dermatitis research.

Takara Bio Inc.

Through a collaboration with Mediford Corporation, provides GLP-compliant safety studies specifically for regenerative medicine products. Services include single-dose toxicity studies tailored to product characteristics, repeated-dose toxicity studies, and in vivo and in vitro tumorigenicity studies. Leveraging extensive experience in gene therapy and cellular medicine, support is available from early research and development through clinical application.

Non-clinical case studies of YAKUKENSHA CO.,LTD.

No case studies are currently listed on the official website.

YAKUKENSHA CO.,LTD. Company Information

YAKUKENSHA CO.,LTD. is a distributor of research equipment, reagents, and consumables, primarily in the life science field. Contributing to research, it also provides online sales and contract services for equipment and technology. It provides products and services that meet the needs of companies and research institutions in a wide range of fields, including pharmaceuticals, chemistry, and biotechnology.